Dynamics in N-terminal pro-brain natriuretic peptide concentration in patients with non-ST-elevation acute coronary syndrome

American Heart Journal

Volumn 150, Issue 6, 2005, Pages 1255-1259

  Riezebos, Robert K ^a   Ronner, Eelko ^a   De Boer, Bauke A ^b   Slaats, Ed H ^b   Tijssen, Jan G P ^c   Laarman, Gert Jan ^a  

^a ONZE LIEVE VROUWE GASTHUIS   (Netherlands)

^b University of Amsterdam ^*  (Netherlands)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

NATRIURETIC FACTOR;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DECISION MAKING; DYNAMICS; FEMALE; HEART MUSCLE ISCHEMIA; HUMAN; MALE; MEASUREMENT; PRIORITY JOURNAL; ST SEGMENT ELEVATION;

ACUTE DISEASE; AGED; BIOLOGICAL MARKERS; CORONARY DISEASE; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; TREATMENT OUTCOME; VENTRICULAR FUNCTION, LEFT;

EID: 28844454667     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2005.02.003     Document Type: Article

References (23)

1. M.S. Sabatine, D.A. Morrow, and J.A. de Lemos Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes: simultaneous assessment of troponin I, C-reactive protein, and B-type natriuretic peptide Circulation 105 2002 1760 1763
2. T. Omland, A. Persson, and L. Ng N-terminal pro-B-type natriuretic peptide and long-term mortality in acute coronary syndromes Circulation 106 2002 2913 2918
3. T. Jernberg, B. Lindahl, and A. Siegbahn N-terminal pro-brain natriuretic peptide in relation to inflammation, myocardial necrosis, and the effect of an invasive strategy in unstable coronary artery disease J Am Coll Cardiol 42 2003 1909 1916
4. J.A. de Lemos, D.A. Morrow, and J.H. Bentley The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes N Engl J Med 345 2001 1014 1021
5. C. Heeschen, C.W. Hamm, and V. Mitrovic Prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes (abstr) Eur Heart J 23 23 Suppl 2002 383
6. D.A. Morrow, J.A. de Lemos, and M.S. Sabatine Evaluation of B-type natriuretic peptide for risk assessment in unstable angina/non-ST-elevation myocardial infarction: B-type natriuretic peptide and prognosis in TACTICS-TIMI 18 J Am Coll Cardiol 41 2003 1264 1272
7. S.K. James, B. Lindahl, and A. Siegbahn N-terminal pro-brain natriuretic peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary artery disease Circulation 108 2003 275 281
8. M. Zeller, Y. Cottin, and Y. Laurent N-terminal pro-brain natriuretic peptide levels in patients with non-ST-elevation myocardial infarction Cardiology 102 2004 37 40
9. M. Galvani, D. Ferrini, and F. Ottani Natriuretic peptides for risk stratification of patients with acute coronary syndromes Eur J Heart Fail 6 2004 327 333
10. T. Jernberg, S. James, and B. Lindahl NT-proBNP in unstable coronary artery disease-experience from the FAST, GUSTO IV and FRISC II trials Eur J Heart Fail 6 2004 319 325
11. K. Marumoto, M. Hamada, and K. Hiwada Increased secretion of atrial and brain natriuretic peptides during acute myocardial ischaemia induced by dynamic exercise in patients with angina pectoris Clin Sci (Lond) 88 1995 551 556
12. S. Talwar, I.B. Squire, and P.F. Downie Profile of plasma N-terminal proBNP following acute myocardial infarction: correlation with left ventricular systolic dysfunction Eur Heart J 21 2000 1514 1521
13. K.J. Yeo, A.H. Wu, and F.S. Apple Multicentre evaluation of the Roche NT-proBNP assay and comparison to the Biosite Triage BNP assay Clin Chim Acta 338 2003 107 115
14. K. Hallermayer, D. Klenner, and R. Vogel Use of recombinant human cardiac troponin T for standardization of third generation troponin T methods Scand J Clin Lab Invest suppl 230 1999 128 131
15. U. Wurzburg, N. Hennrich, and H.D. Orth Quantitative determination of creatine kinase isoenzyme catalytic concentrations in serum using immunological methods J Clin Chem Clin Biochem 15 1977 131
16. S.C. Barbes, D.C. Gaze, and P.O. Collison Preliminary evaluation of NT-proBNP determination on the Elecsys 2010 and 1010 Clin Chem 47 2001 A207
17. A.H. Wu, and A. Smith Biological variation of the natriuretic peptides and their role in monitoring patients with heart failure Eur J Heart Fail 6 2004 335 358
18. Roche Diagnostics ProBNP technical bulletin for Elecsys systems 2003
19. J.P. Goetze, M. Christoffersen, and H. Perko Increased cardiac BNP expression associated with myocardial ischemia FASEB J 17 2003 1105 1107
20. E. Morita, H. Yasue, and M. Yoshimura Increased plasma levels of brain natriuretic peptide in patients with acute myocardial infarction Circulation 88 1993 82 91
21. C. Heeschen, C.W. Hamm, and V. Motrovic N-terminal pro-B-type natriuretic peptide levels for dynamic risk stratification of patients with acute coronary syndromes Circulation 110 2004 3206 3212
22. M.S. Sabatine, D.A. Morrow, and J.A. de Lemos Acute changes in circulating natriuretic peptide levels in relation to myocardial ischemia J Am Coll Cardiol 44 2004 1988 1995
23. D. Gill, T. Seidler, and R.W. Troughton Vigorous response in plasma N-terminal pro-brain natriuretic peptide (NT-BNP) to acute myocardial infarction Clin Sci 106 2004 135 139